Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials.
BMC Neurology · 2020-04-06 · Meta-analysis
Abstract
BACKGROUND: This systematic review and meta-analysis aimed to synthesize the latest evidence on the efficacy and safety of tranexamic acid (TXA) on traumatic brain injury (TBI). METHODS: We performed a systematic literature search on topics that compared intravenous TXA to placebo in patients with TBI up until January 2020 from several electronic databases. RESULTS: There were 30.522 patients from 7 studies. Meta-analysis showed that TXA was associated with reduced mortality (RR 0.92 [0.88, 0.97], p = 0.002; I2: 0%) and hemorrhagic expansion (RR 0.79 [0.64, 0.97], p = 0.03; I2: 0%). Both TXA and control group has a similar need for neurosurgical intervention (p = 0.87) and unfavourable Glasgow Outcome Scale (GOS) (p = 0.59). The rate for vascular occlusive events (p = 0.09), and its deep vein thrombosis subgroup (p = 0.23), pulmonary embolism subgroup (p = 1), stroke subgroup (p = 0.38), and myocardial infarction subgroup (p = 0.15) were similar in both groups. Subgroup analysis on RCTs with low risk of bias showed that TXA was associated with reduced mortality and hemorrhagic expansion. TXA was associated with reduced vascular occlusive events (RR 0.85 [0.73, 0.99], p = 0.04; I2: 4%). GRADE was performed for the RCT with low risk of bias subgroup, it showed a high certainty of evidence for lower mortality, less hemorrhage expansion, and similar need for neurosurgical intervention in TXA group compared to placebo group. CONCLUSION: TXA was associated with reduced mortality and hemorrhagic expansion but similar need for neurosurgical intervention and unfavorable GOS. Vascular occlusive events were slightly lower in TXA group on subgroup analysis of RCTs with low risk of bias.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Haemostatics · Tranexamic acid · Mortality & survival · Quality of life & function
Related articles
- Comparative effectiveness and safety of pharmacological interventions for secondary brain injury in adult traumatic brain injury: a network meta-analysis of randomized trials. (BMC Neurol, 2026)
- Tranexamic acid for neurological outcomes and mortality in adults with hemorrhagic acute brain injury: an updated systematic review and meta-analysis of randomized controlled trials. (Front Neurol, 2026)
- Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis. (Einstein (Sao Paulo), 2025)
- Efficacy and safety of tranexamic acid in acute traumatic brain injury: A meta-analysis of randomized controlled trials. (Am J Emerg Med, 2024)
- Tranexamic acid in patients with traumatic brain injury: a meta-analysis. (Rev Esp Anestesiol Reanim (Engl Ed), 2024)
- Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis. (PLoS One, 2023)